Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations

v3.21.2
Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Operating expenses        
Research and development $ 8,664 $ 4,706 $ 24,462 $ 15,354
General and administrative 3,022 2,607 8,722 8,186
Total operating expenses 11,686 7,313 33,184 23,540
Loss from operations (11,686) (7,313) (33,184) (23,540)
Other income (expense):        
Interest income 36 58 91 154
Other income (expense) 0 10 0 (2,165)
Change in fair value of warrant liabilities 6,358 10,689 17,210 3,800
Total other income, net 6,394 10,757 17,301 1,789
Net (loss) income $ (5,292) $ 3,444 $ (15,883) $ (21,751)
Basic net (loss) income per share $ (0.13) $ 0.12 $ (0.44) $ (1.03)
Shares used in computing basic net (loss) income per share 39,332,721 27,809,169 35,914,327 21,069,057
Diluted net loss per share $ (0.13) $ (0.19) $ (0.44) $ (1.03)
Shares used in computing diluted net (loss) income per share 39,332,721 29,079,107 35,914,327 21,069,057